Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Novavax, Inc.    NVAX

NOVAVAX, INC.

(NVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on NOVAVAX, INC.
03/01/21 FY 2020 Earnings Release (Projected)
05/12/21 Q1 2021 Earnings Release (Projected)
08/10/21 Interim 2021 Earnings Release (Projected)
11/10/21 Q3 2021 Earnings Release (Projected)
Past events on NOVAVAX, INC.
01/11/21 | 08:20am JP Morgan Healthcare Conference
01/08/21 | 11:00am Biotech Showcase Investor Conference
12/03/20 | 02:15pm Evercore ISI HealthCONx Conference
12/02/20 Investor Meeting
Upcoming sector events for NOVAVAX, INC.
01/19/21 AKESO, INC. : R&D Day
01/19/21 | 04:30pm UNITED THERAPEUTICS CORPORATION : Tyvaso Study Results Call
01/20/21 | 06:00am EVOTEC SE : Unicredit & KeplerCheuvreux German Corporate Conference
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
More events
Past sector events for NOVAVAX, INC.
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : #423
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : tps #148
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : tps #142
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : #39
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
36,3
38,8
-6,5%
15,4
15,3
0,26%
31,2
28,7
8,5%
34,3
35,3
-2,8%
18,7
11,8
58%

520
Operating income
(EBITDA)
M $
Released
Forecast
Spread




-154
-149
-3,8%
-166
-158
-4,6%




Operating profit
(EBIT)
M $
Released
Forecast
Spread
-157
-119
-32%
-269
-273
1,5%
-172
-168
-2,1%
-174
-172
-1,3%
-130
-121
-7,5%

-306
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-157
-117
-34%
-280
-284
1,5%
-184
-180
-2,3%
-185
-182
-1,4%
-133
-128
-3,9%

-340
Net income
M $
Released
Forecast
Spread
-157
-117
-34%
-280
-285
1,6%
-184
-180
-2,0%
-185
-182
-1,4%
-133
-130
-2,4%

-314
EPS
$
Released
Forecast
Spread
-12,0
-8,96
-34%
-20,6
-21,0
2,0%
-12,6
-12,4
-1,5%
-10,0
-10,2
2,4%
-5,51
-5,42
-1,6%

-5,49
Announcement Date02/29/201602/27/201703/14/201803/18/201903/11/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
2,51
3,32
-24%
8,82
2,98
195%
3,38
1,93
75%
35,5
39,6
-10%
157
231
-32%

324
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-24,0
-20,4
-18%
-28,7
-24,1
-19%
-22,9
-33,7
32%
-17,0
-16,8
-1,4%
-194
113
-272%

-71,9
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-18,0
-23,3
23%
-31,8
-24,6
-29%
-25,9
-36,3
29%
-17,5
-17,7
0,99%
-197
88,1
-324%

-99,4
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-18,0
-20,7
13%
-31,8
-27,0
-18%
-25,9
-36,9
30%
-17,5
-35,0
50%
-197
109
-280%

-73,8
Net income
$
Released
Forecast
Spread
-0,74
-0,92
19%
-1,13
-1,05
-7,9%
-0,58
-0,71
19%
-0,30
-0,53
44%
-3,21
1,73
-285%

-1,20
Announcement Date11/07/201903/11/202005/11/202008/10/202011/09/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise